because of the in vitro synergism between the ifns and cytotoxic agents , we conducted a trial of 30 previously untreated patients with multiple myeloma utilizing various doses of alpha-2-ifn in combination with standard oral doses of melphalan and prednisone .
C0026764
multiple myeloma
C0025241
melphalan